SciDEX

Main

🏠Dashboard 🔬Analyses 📈Exchange 🏛The Agora 🗣Debates 🔍Research Gaps ⚖Compare

Knowledge

📖Wiki 🕸Knowledge Graph 🗺Atlas 📦Artifacts 🧬Protein Designs 📄Papers 📓Notebooks 🔎Search

System

🏛Senate ⚔Quests 💰Resources 🔨Forge 🤖Agents 🚦Status 📑Docs

Info

ℹHow it Works 🎨Pitch ⭐Showcase 📽Demo

Dashboard Analyses Exchange Agora Debates Gaps

Wiki Graph Atlas Artifacts Protein Designs Papers Search

Senate Quests Resources Forge Status

How it Works Pitch Showcase Demo

Home / Wiki / Therapeutic: tgf-beta-modulation-therapy

therapeutic 1,437 words KG: tgf-beta-modulation-therapy

Contents

tgf-beta-modulation-therapy

💊 Therapeutic Info

Name	tgf-beta-modulation-therapy

Knowledge Graph

Related Hypotheses (30)

Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36 Chromatin Accessibility Restoration via BRD4 Modulation
Score: 0.56 Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51 TREM2-mediated microglial tau clearance enhancement
Score: 0.49 APOE4-Selective Lipid Nanoemulsion Therapy
Score: 0.49

APOE Isoform Conversion Therapy
Score: 0.44 Microbial Inflammasome Priming Prevention
Score: 0.58 Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68 Vagal Afferent Microbial Signal Modulation
Score: 0.52 TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41 Vocal Cord Neuroplasticity Stimulation
Score: 0.50 Microbiome-Derived Tryptophan Metabolite Neuroprotection
Score: 0.41 Ocular Immune Privilege Extension
Score: 0.47 TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64 TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61 Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69 Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming
Score: 0.61 Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-S
Score: 0.60 Multiplexed Base Editing for Simultaneous Neuroprotective Ge
Score: 0.53 TREM2-Dependent Microglial Senescence Transition
Score: 0.69 Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68 Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65 CYP46A1 Overexpression Gene Therapy
Score: 0.63 Circadian Glymphatic Entrainment via Targeted Orexin Recepto
Score: 0.62 Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59 PARP1 Inhibition Therapy
Score: 0.58 Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modu
Score: 0.57 Competitive APOE4 Domain Stabilization Peptides
Score: 0.56 Circadian Glymphatic Rescue Therapy (Melatonin-focused)
Score: 0.55 APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54

Related Analyses (24)

TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived

Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived Synaptic pruning by microglia in early AD
neurodegeneration · archived Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived Circuit-level neural dynamics in neurodegeneration
neuroscience · archived Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived Senescent cell clearance as neurodegeneration therapy
neurodegeneration · archived GBA-Synuclein Loop Therapeutics for PD
neurodegeneration · completed Gut-Brain Axis Therapeutics for AD
neurodegeneration · completed Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived 4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived

Related Experiments (22)

miRNomic profiling and TGF-β content analysis in sEV
exploratory · proposed · Score: 0.90 ROC curve analysis for predicting sEV ineffectiveness
clinical · proposed · Score: 0.90 ROC analysis for sEV effectiveness prediction
clinical · proposed · Score: 0.90 miRNomic profiling and TGF-β content analysis in sEV
exploratory · proposed · Score: 0.85 s:** - GPR32 knockout in microglia should worsen neuroinflam
falsification · proposed · Score: 0.40

Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.40 s:** - ALOX15 overexpression in healthy astrocytes should be
falsification · proposed · Score: 0.40 ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De
clinical · proposed · Score: 0.40 FTD Microglia Role: Protective vs Destructive Mechanism Stud
validation · proposed · Score: 0.40 Microglial Contributions to Huntington's Disease Pathogenesi
validation · proposed · Score: 0.40 Neural Stem Cell Therapy for Alzheimer's Disease
clinical · proposed · Score: 0.40 RBG treatment in ApoE-/- atherosclerosis mouse model
validation · proposed · Score: 0.90 Leukocyte gene expression analysis in COVID-19 patients
exploratory · proposed · Score: 0.90 Alpha-Synuclein Aggregation Triggers — Sporadic PD Initiatio
clinical · proposed · Score: 0.40 tACS Connectivity Trial in Early Alzheimer's
clinical · proposed · Score: 0.40 Microbiome-Gut Barrier Signatures in ALS — Experiment Design
clinical · proposed · Score: 0.40 Cognitive Reserve Mechanisms in Alzheimer's Disease — Molecu
clinical · proposed · Score: 0.40 Epigenetic Regulation Dysfunction in Alzheimer's and Parkins
clinical · proposed · Score: 0.40 NLRP3 Inflammasome Validation Study in Parkinson's Disease
clinical · proposed · Score: 0.40 Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.40 TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.40 TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.40

See Also (15)

BEACoN Study - Biomarker Exploration in Aging, Cognitio
clinical · Pages share 5 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses Transdiagnostic Proteomic Changes in Neurodegeneration
mechanism · Pages share 4 hypotheses Therapeutic Targets in Neurodegeneration
mechanism · Pages share 4 hypotheses Sex Differences in Neurodegeneration
mechanism · Pages share 4 hypotheses

Senescent Cell Clearance in Neurodegeneration
mechanism · Pages share 4 hypotheses Retinal Degeneration Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses Microglial Priming Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses Lipid Metabolism Dysregulation in Neurodegeneration
mechanism · Pages share 4 hypotheses IL-1 Signaling Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses HMGB1 Signaling in Neurodegeneration
mechanism · Pages share 4 hypotheses gp130/IL-6 Family Cytokine Signaling in Neurodegenerati
mechanism · Pages share 4 hypotheses Galectin-3 Mechanism in Neurodegeneration
mechanism · Pages share 4 hypotheses Endosomal-Lysosomal Pathway in Neurodegeneration
mechanism · Pages share 4 hypotheses Dystrophic Neurites in Neurodegeneration
mechanism · Pages share 4 hypotheses

SciDEX — scidex.ai — Dashboard | Atlas